Back to results
US 2019/0169195 A1Published application
Bet protein degraders
AssigneeThe Regents of the University of Michigan
InventorsShaomeng Wang, Bing Zhou, Fuming Xu, Jiantao Hu, Longchuan Bai, Chao-Yie Yang
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compounds represented by Formula I: and the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein B, R1, R5, Q1, Q″, L, X, Y, and Z are as defined as set forth in the specification. The present disclosure also provids compounds of Formula I for use to treat a condition or disorder responsive to degradation of BET bromodomains such as cancer.
Claims85
A compound having Formula I:
- or a pharmaceutically acceptable salt or solvate thereof, wherein:
- B is selected from the group consisting of:
- R1 is selected from the group consisting of optionally substituted aryl, optionally substituted heteroaryl, and —N(H)R3;
- Q1 is ═CH— and Q2 is —N═;
- or
- Q1 is ═N— and Q2 is —CH═;
- or
- Q1 is ═N— and Q2 is —N═;
- R3 is selected from the group consisting of optionally substituted aryl and optionally substituted heteroaryl;
- X is selected from the group consisting of —C(═O)N(R2a)—, —CH2N(R2b)—, —CH2O—, —N(R2c)—, —O—, and —CH2—;
- wherein the nitrogen atom of —C(═O)N(R2a)— and —CH2N(R2b)— is attached to L, and the oxygen atom of —CH2O— is attached to L;
- L is selected from the group consisting of alkylenyl, heteroalkylenyl, and —(CH2)m—W—(CH2)n—;
- W is selected from the group consisting of optionally substituted phenylenyl, optionally substituted 5-membered heteroarylenyl, and optionally substituted 6-membered heteroarylenyl;
- m is 0, 1, 2, 3, 4, 5, 6, or 7;
- n is 0, 1, 2, 3, 4, 5, 6, 7, or 8;
- Y is selected from the group consisting of —C≡C—, —CH2—, —O—, —N(R2d)—, —C(═O)N(R2e)—, —N(R2f)C(═O)CH2O—, and —N(R2g)C(═O)CH2N(R2h)—;
- or
- Y is absent;
- wherein the carboxamide nitrogen atom of —N(R2f)C(═O)CH2O— and —N(R2g)C(═O)CH2N(R2h)—, and the carbon atom of —C(═O)N(R2e)— is attached to L;
- R2a, R2b, R2c, R2d, R2e, R2f, R2g, and R2h are each independently selected from the group consisting of hydrogen and C1-4 alkyl;
- Z is selected from the group consisting of —CH2 and —C(═O)—;
- and
- R5 is selected from the group consisting of hydrogen and fluoro,
- with the proviso that Y is absent when B is B-2.
21 more elements
A compound having Formula XIV:
- or a pharmaceutically acceptable salt or solvate thereof, wherein:
- R1 is selected from the group consisting of optionally substituted aryl, optionally substituted heteroaryl, and —N(H)R3;
- Q1 is ═CH— and Q2 is —N═;
- or
- Q1 is ═N— and Q2 is —CH═;
- or
- Q1 is ═N— and Q2 is —N═;
- R3 is selected from the group consisting of optionally substituted aryl and optionally substituted heteroaryl;
- R7a is selected from the group consisting of chloro and —OR7b;
- and
- R7b is selected from the group consisting of hydrogen and C1-4 alkyl.
8 more elements
Dependencies are inferred from the claim text.